201 related articles for article (PubMed ID: 34370914)
1. Prevalence of periapical abscesses in patients with rheumatoid arthritis. A cross sectional study.
Rotstein I; Katz J
Am J Dent; 2021 Aug; 34(4):211-214. PubMed ID: 34370914
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Periapical Abscesses in Patients with Hypertension: A Cross-sectional Study of a Large Hospital Population.
Katz J; Rotstein I
J Endod; 2021 Jul; 47(7):1070-1074. PubMed ID: 33862105
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of periapical abscesses in patients with systemic lupus erythematosus.
Rotstein I; Katz J
Spec Care Dentist; 2022 Jan; 42(1):15-19. PubMed ID: 34240444
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of periapical abscesses in vitamin D deficient patients.
Rotstein I; Katz J
Am J Dent; 2021 Jun; 34(3):163-165. PubMed ID: 34143587
[TBL] [Abstract][Full Text] [Related]
5. Periapical disease in post-stroke patients.
Rotstein I; Katz J
Am J Dent; 2022 Aug; 35(4):197-199. PubMed ID: 35986935
[TBL] [Abstract][Full Text] [Related]
6. Acute periapical abscesses in patients using selective serotonin reuptake inhibitors.
Rotstein I; Katz J
Spec Care Dentist; 2024; 44(1):143-147. PubMed ID: 36200767
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
[TBL] [Abstract][Full Text] [Related]
8. Therapies for active rheumatoid arthritis after methotrexate failure.
O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E;
N Engl J Med; 2013 Jul; 369(4):307-18. PubMed ID: 23755969
[TBL] [Abstract][Full Text] [Related]
9. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
[TBL] [Abstract][Full Text] [Related]
10. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
[TBL] [Abstract][Full Text] [Related]
12. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
Karlsson JA; Neovius M; Nilsson JÅ; Petersson IF; Bratt J; van Vollenhoven RF; Ernestam S; Geborek P
Ann Rheum Dis; 2013 Dec; 72(12):1927-33. PubMed ID: 23196701
[TBL] [Abstract][Full Text] [Related]
13. Increased Risk for Acute Periapical Abscesses in Multiple Sclerosis Patients and the Possible Association with Epstein-Barr Virus.
Rotstein I; Katz J
J Endod; 2023 Mar; 49(3):262-266. PubMed ID: 36526109
[TBL] [Abstract][Full Text] [Related]
14. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
Smolen JS; Nash P; Durez P; Hall S; Ilivanova E; Irazoque-Palazuelos F; Miranda P; Park MC; Pavelka K; Pedersen R; Szumski A; Hammond C; Koenig AS; Vlahos B
Lancet; 2013 Mar; 381(9870):918-29. PubMed ID: 23332236
[TBL] [Abstract][Full Text] [Related]
15. Atherosclerotic cardiovascular disease in rheumatoid arthritis.
del Rincón I; Escalante A
Curr Rheumatol Rep; 2003 Aug; 5(4):278-86. PubMed ID: 14531955
[TBL] [Abstract][Full Text] [Related]
16. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of dermatophytosis in patients with rheumatoid arthritis.
Bicer A; Tursen U; Cimen OB; Kaya TI; Ozisik S; Ikizoglu G; Erdogan C
Rheumatol Int; 2003 Jan; 23(1):37-40. PubMed ID: 12548440
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and risk factors of cardiovascular disease in patients with elderly-onset rheumatoid arthritis: A large cross-sectional clinical study].
Chen JL; Jin YB; Wang YF; Zhang XY; Li J; Yao HH; He J; Li C
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1040-1047. PubMed ID: 33331311
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Periapical Lesions in Patients with Osteoporosis.
Katz J; Rotstein I
J Endod; 2021 Feb; 47(2):234-238. PubMed ID: 33130060
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
Klareskog L; van der Heijde D; de Jager JP; Gough A; Kalden J; Malaise M; Martín Mola E; Pavelka K; Sany J; Settas L; Wajdula J; Pedersen R; Fatenejad S; Sanda M;
Lancet; 2004 Feb; 363(9410):675-81. PubMed ID: 15001324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
